Navigation Links
NPS Pharmaceuticals to Report 2007 Financial Results
Date:3/6/2008

BEDMINSTER, N.J., March 6 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its 2007 financial results on Thursday, March 13, 2008 post-market. The announcement will be followed by a conference call and webcast at 5:00 p.m. Eastern Time.

To participate in the conference call, dial (866) 510-0708 and use passcode 19613979. International callers may dial (617) 597-5377, using the same passcode. In addition, a live audio of the conference call will be available over the Internet. Interested parties can access the event through the NPS website, http://www.npsp.com.

If you are unable to participate in the live call, a replay will be available at (888) 286-8010, with passcode 39947050, until midnight Eastern Time, March 28, 2008. International callers may access the replay by dialing (617) 801-6888, using the same passcode. The webcast will also be available through the NPS website for the same period.

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing high value specialty therapeutics for gastrointestinal and endocrine disorders. The company is currently advancing two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs with strategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.


'/>"/>
SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... BEVERLY HILLS, CA (PRWEB) , ... March 01, 2017 , ... ... invasive cryoablation for the treatment of early stage breast cancer and where it fits ... Screens, Genes & The Choices We Make .” The event brings together leading cancer ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living ... mobile app Time & Go. , Time & Go app is the ultimate strategic ... and well-being. Efficient time management methods enable people to work smarter, not harder, that's ...
(Date:3/1/2017)... , ... March 01, 2017 , ... March 2017 – ... months when people don’t want to stop training to brave the cold weather, snow ... treadmill to a small incline can help protect these vulnerable joints, says orthopaedic surgeon ...
(Date:3/1/2017)... ... March 01, 2017 , ... “McFarnia”: a suspenseful tale ... the truth about his life and mysterious disappearance. “McFarnia” is the creation of published ... in North Carolina. He currently serves as a Chaplain with Transport for Christ at ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a ... author, Maria Teresa Hamilton, survivor of the Civil War in El Salvador, wife, mother, ... the age of fifteen. I dedicated myself to serve in very poor communities, and ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... , March 1, 2017  The Pharmaceutical Care ... Senate Finance Committee,s vote to advance the nomination of ... Medicare and Medicaid Services Administrator: "The ... bright spot in American health care. By offering an ... using cutting-edge, cost-saving tools like pharmacy networks and home ...
(Date:3/1/2017)... , March 1, 2017 The global  Intraoperative Neuromonitoring (IONM) ... new report by Grand View Research, Inc. The intraoperative neuromonitoring market is anticipated ... the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries. ... ... Grand View Research Logo ...
(Date:2/28/2017)... Mechanical Ventilators Market: Scope of the Study ... This report provides forecast and analysis of the mechanical ... provides historical data of 2015 along with forecast from ... and volume (units). The report also includes macroeconomic indicators ... It includes drivers and restraints of the mechanical ventilators ...
Breaking Medicine Technology: